QA and GMP- knowledge and practice: Preponderance in pharma industries

The quality of pharmaceuticals has been a concern of the World Health Organization (WHO) since its inception. The setting of global standards is cites as one of the Organization’s functions that it should “develop, establish and promote international standards with respect to food, biological, pharmaceutical and similar products.” This proportion tends to be greatest in developing countries, where it may exceed 40%.Without assurance that these medicines are relevant to priority health needs and that they meet acceptable standards of quality, safety and efficacy, any health service is evidently compromised. In developing countries considerable administrative and technical effort is directed to ensuring that patients receive effective medicines of good quality. It is crucial to the objective of health for all that a reliable system of medicines control be brought within the reach of every country. hence the knowledge of QA and GMP is very essential and should be opted in full practice by pharma industries.